Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 37 are a HOLD (13.75%), 224 are a BUY (83.27%), 8 are a SELL (2.97%).
Analyst Mark Massaro works at BTIG with a stock forecast success ratio of 48.26% fulfilled within 138.21 days on average.
Mark Massaro’s has documented 519 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MXCT, MaxCyte at 13-Mar-2024.
Analyst best performing recommendations are on HTGM (HTG MOLECULAR DIAGNOSTICS).
The best stock recommendation documented was for HTGM (HTG MOLECULAR DIAGNOSTICS) at 6/2/2015. The price target of $3060 was fulfilled within 1 day with a profit of $151.2 (5.2%) receiving and performance score of 51.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
$2.11 (73.01%)
63
1 months 12 days ago
1/3 (33.33%)
$1.15 (29.87%)
201
Buy
6
$3.11 (107.61%)
13
4 months 15 days ago
5/10 (50%)
$2.54 (73.41%)
56
Hold
10
$7.11 (246.02%)
13
5 months 4 days ago
1/6 (16.67%)
$5.31 (113.22%)
5
Sell
7
$4.11 (142.21%)
8
1 years 1 months 13 days ago
2/2 (100%)
$-3.03 (-30.21%)
50
Buy
15
$9.55 (175.23%)
1 years 2 months 23 days ago
0/1 (0%)
$6.92 (85.64%)
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?